evidence card · statins_reduce_inflammation_rcts
Statins reduce inflammatory markers (hs-CRP) robustly in RCTs
H4
▲ supports
stakes moderate
2 posts scored
·
across 1 account
·
2 sources
Summary
JUPITER (rosuvastatin, elevated hs-CRP) and multiple other RCTs show consistent CRP reduction with statins. CANTOS (canakinumab) independently showed anti-inflammatory effect reduces events.
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
adults with elevated or normal CRP on statin therapy
Intervention
statin therapy
Outcome
hs-CRP, other inflammatory markers
Not supported for
- claim that statin anti-inflammatory effect independent of LDL lowering drives clinical benefit